Pulmatrix (PULM) EBT (2013 - 2026)
Pulmatrix (PULM) posted EBT of -$1.3 million for Q1 2026, up 95.37% sequentially from -$28.7 million in Q4 2025, and up 27.12% YoY from -$1.0 million in Q1 2025.
Pulmatrix (PULM) EBT (2013 - 2026) Analysis & Trends
Pulmatrix has reported EBT for 14 years, with the latest figure at -$1.3 million in Q1 2026.
- Quarterly EBT rose 27.12% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$32.5 million (down 162.28% YoY) and the FY2025 annual result came in at -$32.9 million, down 229.5% from the prior year.
- EBT rose to -$1.3 million in Q1 2026 per PULM's latest filing, from -$28.7 million in the prior quarter.
- Over five years, EBT peaked at -$846000.0 in Q3 2025 and troughed at -$28.7 million in Q4 2025.
- A 5-year average of -$5.7 million and a median of -$4.8 million in 2022 frame the typical range for EBT.
- The widest YoY moves for EBT: up 86.47% in 2025, down 1429.38% in 2025.
- Over 5 years, EBT stood at -$4.8 million in 2022, then surged by 55.5% to -$2.1 million in 2023, then climbed by 11.24% to -$1.9 million in 2024, then slumped by 1429.38% to -$28.7 million in 2025, then soared by 95.37% to -$1.3 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$1.3 million, -$28.7 million, and -$846000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Pulmatrix | 5.66 Mn | 5.66 Mn | - | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.09 Mn |
| Mar 31, 2026 | -1.33 Mn |
| Dec 31, 2025 | -28.74 Mn |
| Sep 30, 2025 | -846,000.00 |
| Jun 30, 2025 | -1.54 Mn |
| Mar 31, 2025 | -1.83 Mn |
| Dec 31, 2024 | -1.88 Mn |
| Sep 30, 2024 | -2.58 Mn |
| Jun 30, 2024 | -6.09 Mn |
| Mar 31, 2024 | -13.49 Mn |
| Dec 31, 2023 | -2.12 Mn |
| Sep 30, 2023 | -6.64 Mn |
| Jun 30, 2023 | -4.42 Mn |
| Mar 31, 2023 | -5.02 Mn |
| Dec 31, 2022 | -4.76 Mn |
| Sep 30, 2022 | -5.53 Mn |
| Jun 30, 2022 | -4.87 Mn |
| Mar 31, 2022 | -5.27 Mn |
| Dec 31, 2021 | -4.34 Mn |
| Sep 30, 2021 | -8.49 Mn |